Logo - springer
Slogan - springer

Biomedical Sciences - Human Genetics | Journal of Molecular Medicine - incl. option to publish open access (Societies)

Journal of Molecular Medicine

Journal of Molecular Medicine

Editor-in-Chief: Ari Waisman

ISSN: 0946-2716 (print version)
ISSN: 1432-1440 (electronic version)

Journal no. 109

$199.00 Personal Rate e-only for the Americas
Get Subscription

Online subscription, valid from January through December of current calendar year

Immediate access to this year's issues via SpringerLink

1 Volume(-s) with 12 issue(-s) per annual subscription

Automatic annual renewal

More information: >> FAQs // >> Policy

Editorial Team

Associate Editors 

Anthony P. Monaco 

Tufts University, Medford

Anthony P Monaco
Anthony P. Monaco is the current president of Tufts University in Medford, Massachusetts, USA, and a visiting professor at the Wellcome Trust Center for Human Genetics, University of Oxford, Oxford, UK. His research interests focus on the genetic basis of neurodevelopmental disorders including autism, specific language impairment and reading disorders (dyslexia). His group's significant achievements include the identification of a gene (KIAA0319) involved in susceptibility to dyslexia and the identification of Forkhead-Box-Protein P2 (FOXP2), the first gene specifically involved in human speech and language.

Jonathan Sleeman 

University of Heidelberg, Medical Faculty Mannheim, Germany

Jonathan Sleeman is Professor of Microvascular Biology and Pathobiology at the University of Heidelberg, Germany (Medical Faculty Mannheim) and is also affiliated with KIT Karlsruhe, Germany.
Dr. Sleeman’s research aims to understand the cellular and molecular regulation of metastasis and to use this knowledge to develop novel anti-cancer therapies. This work currently encompasses studies on (a) genetic changes and signalling pathways that promote metastasis; (b) tumor-induced lymphangiogenesis and dissemination via the lymphatics; (c) the involvement of cancer stem cells and niche structures in metastatic spread and dormancy; (d) changes in extracellular matrix components (in particular hyaluronic acid) and pro-inflammatory signaling molecules as regulators of dissemination and metastatic outgrowth.

Makoto Suematsu  

Keio University, Tokyo

Makoto Suematsu
Makoto Suematsu’s research focuses on Gas Biology and Medicine. He has revealed that carbon monoxide generated in our body serves as a potent regulator of microvascular tone. The fact that gases target metal-centered prosthetic groups of proteins has led him to apply advanced metabolome analysis and imaging MS for exploring gas-responsive macromolecules in biological systems and to investigate their medical implications.

Danny Welch 

Danny Welch
Danny Welch´s research aims at determining the mechanisms by which tumor cells acquire the ability to metastasize. In recent years his group has focused on metastasis suppressors and they have cloned six of them: KISS1, BRMS1, TXNIP, CRSP3 and two microRNA. When metastatic cancer cells are engineered to re-express metastasis suppressors, metastasis is suppressed without blocking tumor formation. The current focus of the lab is to understand the mechanisms by which these molecules block metastasis.

Cornelia Weyand  

Stanford University, Stanford

Cornelia Weyand
Cornelia Weyand´s main research interests are in the role of the immune system in chronic inflammatory disease and the immuno-stromal interactions that shape tissue inflammation. In recent years her laboratory has studied the impact of immune aging on protective and damaging immune responses and has identified deficiencies in the molecular machinery of telomere protection, DNA damage sensing and DNA repair as elements in premature immune aging. Her team has defined tissue-injurious immune effector mechanisms in vascular inflammation with emphasis on vasculitis and atherosclerosis.

For authors and editors

  • Journal Citation Reports®
    2016 Impact Factor
  • 4.686
  • Aims and Scope

    Aims and Scope


    The Journal of Molecular Medicine publishes reports describing major advances in the understanding, prevention, diagnosis, or treatment of human disease through the application of molecular biology and gene technology, a research discipline that has become known as molecular medicine.

    The journal publishes original papers and review articles of the highest quality pertinent to all aspects of human biology and pathophysiology. Covered areas include, but are not limited to:
    aging, angiogenesis, cancer biology and oncology, development and differentiation, endocrinology and metabolic disorders, gastrointestinal diseases and hepatology, genetics and epigenetics, hematology, hypoxia research, immunology, infectious diseases, neuroscience of diseases, -omics based research of diseases, systems medicine, regenerative medicine, stem cell research, vascular and cardiovascular biology.

    Good reasons for publishing your best paper in J Mol Med:

    • High impact: 4.768 (2012 IF)
    • Wide distribution: More than 8,100 institutions worldwide having full text access
    • Wide readership: Almost 29,000 full text downloads per month
    • Rapid editorial handling: 17 days from submission to first decision
    • Rapid publication: 19 days from acceptance to online publication
    • Commitment to fairness: Author feedback program
    • No page charges, no submission charges

     J Mol Med is the continuation of the Berliner Klinische Wochenschrift (1864), one of the oldest and most prestigious European journals in which great scientists such as Paul Ehrlich, Robert Koch and Otto Warburg published their seminal, epoch-making discoveries.

  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for Authors

    Instructions for Authors


  • Everything an Author Needs

    Everything an Author Needs


  • Author Academy: Training for Authors
  • Copyright Information

    Copyright Information


    Copyright Information

    For Authors

    Submission of a manuscript implies: that the work described has not been published before (except in form of an abstract or as part of a published lecture, review or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as – tacitly or explicitly – by the responsible authorities at the institution where the work was carried out.

    Author warrants (i) that he/she is the sole owner or has been authorized by any additional copyright owner to assign the right, (ii) that the article does not infringe any third party rights and no license from or payments to a third party is required to publish the article and (iii) that the article has not been previously published or licensed. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. Transfer of copyright to Springer (respective to owner if other than Springer) becomes effective if and when a Copyright Transfer Statement is signed or transferred electronically by the corresponding author. After submission of the Copyright Transfer Statement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted by Springer.

    The copyright to this article, including any graphic elements therein (e.g. illustrations, charts, moving images), is assigned for good and valuable consideration to Springer effective if and when the article is accepted for publication and to the extent assignable if assignability is restricted for by applicable law or regulations (e.g. for U.S. government or crown employees).

    The copyright assignment includes without limitation the exclusive, assignable and sublicensable right, unlimited in time and territory, to reproduce, publish, distribute, transmit, make available and store the article, including abstracts thereof, in all forms of media of expression now known or developed in the future, including pre- and reprints, translations, photographic reproductions and microform. Springer may use the article in whole or in part in electronic form, such as use in databases or data networks for display, print or download to stationary or portable devices. This includes interactive and multimedia use and the right to alter the article to the extent necessary for such use.

    Authors may self-archive the Author's accepted manuscript of their articles on their own websites. Authors may also deposit this version of the article in any repository, provided it is only made publicly available 12 months after official publication or later. He/she may not use the publisher's version (the final article), which is posted on SpringerLink and other Springer websites, for the purpose of self-archiving or deposit. Furthermore, the Author may only post his/her version provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com".

    Prior versions of the article published on non-commercial pre-print servers like arXiv.org can remain on these servers and/or can be updated with Author's accepted version. The final published version (in pdf or html/xml format) cannot be used for this purpose. Acknowledgement needs to be given to the final publication and a link must be inserted to the published article on Springer's website, accompanied by the text "The final publication is available at link.springer.com". Author retains the right to use his/her article for his/her further scientific career by including the final published journal article in other publications such as dissertations and postdoctoral qualifications provided acknowledgement is given to the original source of publication.

    Author is requested to use the appropriate DOI for the article. Articles disseminated via link.springer.com are indexed, abstracted and referenced by many abstracting and information services, bibliographic networks, subscription agencies, library networks, and consortia.

    For Readers

    While the advice and information in this journal is believed to be true and accurate at the date of its publication, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may have been made. The publisher makes no warranty, express or implied, with respect to the material contained herein.

    All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g., as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining written permission from the publisher (respective the copyright owner if other than Springer). The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

    Springer has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Springer content. For permission to reuse our content please locate the material that you wish to use on link.springer.com or on springerimages.com and click on the permissions link or go to copyright.com, then enter the title of the publication that you wish to use. For assistance in placing a permission request, Copyright Clearance Center can be connected directly via phone: +1-855-239-3415, fax: +1-978-646-8600, or e-mail: info@copyright.com.

    © Springer-Verlag Berlin Heidelberg

Services for the Journal

Alerts for this journal


Get the table of contents of every new issue published in Journal of Molecular Medicine.